中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

30 records (took 0.033 seconds)

    OBSTRUCTIVE AND CENTRAL SLEEP APNEA COMBINATION THERAPY CONTROL
    21.
    发明申请
    OBSTRUCTIVE AND CENTRAL SLEEP APNEA COMBINATION THERAPY CONTROL 有权

    公开(公告)号：US20230001200A1

    公开(公告)日：2023-01-05

    申请号：US17930645

    申请日：2022-09-08

    Applicant: Medtronic, Inc.

    Inventor： Randal C. Schulhauser ,  Avram Scheiner ,  Linnea R. Lentz

    IPC: A61N1/36 ,  A61B5/318 ,  A61B5/053 ,  A61N1/05 ,  A61B5/00 ,  A61B5/08

    Abstract: Apnea events may be detected based on a primary biomarker, e.g., respiration, in the one or more physiological signals. The apnea events may be characterized as one of an obstructive sleep apnea (OSA) event, a central sleep apnea (CSA) event, or a combination OSA/CSA event based on a secondary biomarker, e.g., a frequency spectrum or a morphology of the respirations in the one or more physiological signals. A first electrical stimulation may be provided to treat OSA in response to a first one or more of the apnea events being characterized as OSA events. A second electrical stimulation may be provided to treat CSA in response to a second one or more of apnea events being characterized as CSA events. A third electrical stimulation may be provided to treat combination OSA/CSA in response to a third one or more of the apnea events being characterized as combination OSA/CSA events.

    METHOD AND APPARATUS FOR STIMULATION
    22.
    发明申请
    METHOD AND APPARATUS FOR STIMULATION 有权

    公开(公告)号：US20220339440A1

    公开(公告)日：2022-10-27

    申请号：US17812351

    申请日：2022-07-13

    Applicant: Medtronic, Inc.

    Inventor： Avram Scheiner

    IPC: A61N1/36 ,  A61N1/372 ,  A61N1/02 ,  A61F5/56 ,  A61B5/00

    Abstract: A medical device system and method are disclosed for treating obstructive sleep apnea. The system includes a pulse generator and a medical electrical lead including multiple electrodes carried by a distal portion of an elongated lead body. The method includes advancing the distal portion within protrusor muscle tissue below the oral cavity and delivering electrical stimulation pulses via the electrodes to sustain a protruded state throughout a delivery time period to sustain a protruded state of a patient's tongue throughout the therapy delivery time period. The therapy delivery time period may span multiple respiration cycles.

    Obstructive and central sleep apnea combination therapy control
    23.
    发明授权
    Obstructive and central sleep apnea combination therapy control 有权

    公开(公告)号：US11464977B2

    公开(公告)日：2022-10-11

    申请号：US17194943

    申请日：2021-03-08

    Applicant: Medtronic, Inc.

    Inventor： Randal C. Schulhauser ,  Avram Scheiner ,  Linnea R. Lentz

    IPC: A61N1/36 ,  A61B5/318 ,  A61B5/053 ,  A61N1/05 ,  A61B5/00 ,  A61B5/08

    Abstract: Apnea events may be detected based on a primary biomarker, e.g., respiration, in the one or more physiological signals. The apnea events may be characterized as one of an obstructive sleep apnea (OSA) event, a central sleep apnea (CSA) event, or a combination OSA/CSA event based on a secondary biomarker, e.g., a frequency spectrum or a morphology of the respirations in the one or more physiological signals. A first electrical stimulation may be provided to treat OSA in response to a first one or more of the apnea events being characterized as OSA events. A second electrical stimulation may be provided to treat CSA in response to a second one or more of apnea events being characterized as CSA events. A third electrical stimulation may be provided to treat combination OSA/CSA in response to a third one or more of the apnea events being characterized as combination OSA/CSA events.

    NEURAL STIMULATION TO TREAT SLEEP APNEA
    26.
    发明申请
    NEURAL STIMULATION TO TREAT SLEEP APNEA 审中-公开

    公开(公告)号：US20190117967A1

    公开(公告)日：2019-04-25

    申请号：US16227391

    申请日：2018-12-20

    Applicant: Medtronic, Inc.

    Inventor： Avram Scheiner

    IPC: A61N1/36 ,  A61F5/56 ,  A61N1/05 ,  A61B5/00 ,  A61B5/11 ,  A61N1/372

    Abstract: A removable oral device is disclosed. The removable oral device comprises a mounting retainer configured to align with a set of teeth. An electrical stimulator is coupled to the mounting retainer. A single lead is employed that has a first and a second end and lacking a mechanical connection to the mounting retainer. A first and a second electrode are positioned along the single lead. The lead is disposed perpendicular to a longitudinal axis of a patient's tongue such that the first electrode is proximate a first hypoglossal nerve and the second electrode is proximate a second hypoglossal nerve.

Patent Agency Ranking